Cardiovascular Business
Cardiovascular Business serves as a source for news, business insights, and technological advancements in the field of cardiovascular medicine. We concentrate on the economic aspects and business strategies that support leading clinical practices, interventional methods, surgical innovations, and information technologies. Additionally, we cover pharmaceuticals and related products that play a crucial role in establishing a successful integrated cardiovascular practice.
Outlet metrics
Global
#339273
United States
#105656
Health/Health
#2159
Articles
-
2 days ago |
cardiovascularbusiness.com | Dave Fornell
The Trump administration has made it a priority to take federal funding away from any group it considers to be "DEI." These policies have even led to the removal of healthcare data from government websites. Funding cuts have most directly impacted patient care for prevention programs aimed at underserved communities. They have also impacted patients involved in clinical trials looking specifically at female and non-white populations.
-
4 days ago |
cardiovascularbusiness.com | Dave Fornell
The American Society of Nuclear Cardiology (ASNC), in collaboration with the American Medical Association (AMA), is taking a firm stance against health insurance companies’ growing use of artificial intelligence (AI) to automate prior authorization denials—an approach that physicians say is undermining patient care and contributing to professional burnout.
-
1 week ago |
cardiovascularbusiness.com | Dave Fornell
Cardiovascular disease remains the leading cause of death for women, and growing evidence shows that men and women experience heart disease in fundamentally different ways. Those differences need to be more fully reflected in clinical guidelines, according to Janet Wei, MD, Erika J. Glazer Chair in Women’s Cardiovascular Research, Education and Innovation at the Smidt Heart Institute at Cedars-Sinai Hospital. She explained that heart disease is not a one-size-fits-all condition.
-
2 weeks ago |
cardiovascularbusiness.com | Michael Walter
The concept of using transcatheter aortic valve replacement (TAVR) to treat asymptomatic patients has gained considerable momentum in recent months. However, not everyone is cardiology agrees that this is necessarily the best path forward.
-
2 weeks ago |
cardiovascularbusiness.com | Michael Walter
Medtronic has announced that MiniMed will be the name of its planned diabetes spin-off. MiniMed was also the original name of the medtech giant’s diabetes business before it was acquired by Medtronic in 2001. The news comes just weeks after Medtronic announced its plans to turn its California-based diabetes business into a separate publicly traded company. The standalone entity includes a team of more than 8,000 employees.
Cardiovascular Business journalists
Contact details
Address
123 Example Street
City, Country 12345
Email Patterns
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →